Thrivent Financial for Lutherans’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-50,384
Closed -$1.67M – 2473
2022
Q2
$1.67M Sell
50,384
-509,460
-91% -$21.6M ﹤0.01% 1349
2022
Q1
$40.4M Buy
559,844
+68,971
+14% +$4.97M 0.08% 286
2021
Q4
$45.1M Buy
490,873
+40,670
+9% +$4.86M 0.09% 269
2021
Q3
$57.1M Buy
450,203
+23,683
+6% +$3.45M 0.12% 214
2021
Q2
$70.9M Buy
426,520
+89,761
+27% +$14.5M 0.14% 180
2021
Q1
$61.2M Buy
336,759
+4,443
+1% +$1.03M 0.13% 193
2020
Q4
$66.5M Buy
332,316
+133,890
+67% +$27.2M 0.15% 165
2020
Q3
$43.5M Buy
+198,426
New +$42M 0.12% 213
2020
Q2
– Sell
-8,058
Closed -$1.25M – 2303
2020
Q1
$1.25M Buy
+8,058
New +$937K ﹤0.01% 1173

Other funds holding TDOC

Thrivent Financial for Lutherans's TDOC Position: Q3 2022 in Review

Thrivent Financial for Lutherans sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 50,384 shares — an estimated $1.67M sold.

Thrivent Financial for Lutherans first reported a position in TDOC in Q1 2020 and held it in 9 quarters. The position peaked at $70.9M in Q2 2021. 483 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Thrivent Financial for Lutherans reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 50,384 Teladoc Health shares in Q3 2022, an estimated $1.67M.
  • Thrivent Financial for Lutherans first reported a position in Teladoc Health in Q1 2020 and held it in 9 quarters.
  • Thrivent Financial for Lutherans's Teladoc Health position peaked at $70.9M in Q2 2021.
  • 483 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2022, filed 14 Nov 2022.